ADHD Drug Shortages Spread to Generic Ritalin (1)

Jan. 6, 2023, 2:25 PM UTC

Shortages of ADHD medications that started this summer with Adderall have widened to now include another major category of stimulants.

For the past two months, patients have had a hard time finding methylphenidate drugs, a class that includes Novartis AG’s Ritalin and Johnson & Johnson’s Concerta. A drug manufacturer and a major pharmacy told Bloomberg News there are issues with the supply of the drugs, though it’s unclear what’s causing the shortage.

There has been a shortage of ADHD stimulant medications, taken by millions in the US each month, since August, starting with amphetamine-based drugs like Adderall. ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.